Page last updated: 2024-08-24

etofibrate and Hyperlipoproteinemia

etofibrate has been researched along with Hyperlipoproteinemia in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	9 (81.82)	18.7374
1990's	1 (9.09)	18.2507
2000's	1 (9.09)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goebel, KM; Hausmann, L; Kaffarnik, H; Schneider, J; Schubotz, R; Zöfel, P	1
Bochenek, W; Słowińska, R; Unlot, J	1
Schatton, W	1
Kaffarnik, H; Schneider, J; Schubotz, R; Zöfel, P	1
Djaja, S; Machalke, K; Richter, E	1
von Bock und Polach, U	1
Steger, W	1
Fenselau, S; Schrezenmeir, J; Steinmetz, A	1
Kłosiewicz-Latoszek, L; Szostak, WB	1
Holm, E; Schatton, W	1

Reviews

1 review(s) available for etofibrate and Hyperlipoproteinemia

Article	Year
Treatment of dyslipoproteinemia in the metabolic syndrome. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2001, Volume: 109, Issue:4 Topics: Arteriosclerosis; Clofibric Acid; Coronary Disease; Diabetes Mellitus, Type 2; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Metabolic Syndrome	2001

Article

Year

Treatment of dyslipoproteinemia in the metabolic syndrome.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2001, Volume: 109, Issue:4

Topics: Arteriosclerosis; Clofibric Acid; Coronary Disease; Diabetes Mellitus, Type 2; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Metabolic Syndrome

2001

Trials

4 trial(s) available for etofibrate and Hyperlipoproteinemia

Article	Year
[Study of the antilipemic effect of etofibrate (Lipo-Merz)]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1983, Apr-25, Volume: 38, Issue:17 Topics: Adult; Aged; Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged	1983
[Pharmacology and mechanism of action of etofibrate]. Die Medizinische Welt, 1982, Sep-24, Volume: 33, Issue:38 Topics: Animals; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipids	1982
[Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias]. Therapie der Gegenwart, 1982, Volume: 121, Issue:5 Topics: Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Theophylline; Xanthinol Niacinate	1982
[Therapy of lipoproteinemia. Comparison between Lipo-Merz retard and a commercial combination drug]. Fortschritte der Medizin, 1980, May-15, Volume: 98, Issue:18 Topics: Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Drug Combinations; Drug Evaluation; Female; Humans; Hyperlipoproteinemias; Male; Middle Aged; Niacin; Nicotinic Acids; Triglycerides	1980

Other Studies

6 other study(ies) available for etofibrate and Hyperlipoproteinemia

Article	Year
Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observations. Artery, 1980, Volume: 8, Issue:6 Topics: Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Creatine Kinase; Female; gamma-Glutamyltransferase; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Long-Term Care; Male; Middle Aged; Triglycerides; Uric Acid	1980
[Longterm therapy and etofibrate (author's transl)]. MMW, Munchener medizinische Wochenschrift, 1980, Jan-18, Volume: 122, Issue:3 Topics: Anticholesteremic Agents; Blood Cell Count; Blood Glucose; Clofibrate; Clofibric Acid; Drug Administration Schedule; Drug Tolerance; Humans; Hyperlipoproteinemias; Triglycerides	1980
[Lowering lipids rapidly and permanently with etofibrate]. Medizinische Klinik, 1982, Jan-29, Volume: 77, Issue:3 Topics: Cholestyramine Resin; Clofibrate; Clofibric Acid; Dextrothyroxine; Humans; Hyperlipoproteinemias; Lipoproteins, HDL; Liver; Nicotinic Acids; Sitosterols	1982
[What is important in therapy of hyperlipoproteinemia. Lipo-Merz retard (etofibrate) lowers the atherogenic index]. Fortschritte der Medizin, 1982, Sep-16, Volume: 100, Issue:35 Topics: Anticholesteremic Agents; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Humans; Hyperlipoproteinemias	1982
Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia. European journal of clinical pharmacology, 1991, Volume: 40, Issue:1 Topics: Adult; Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Colestipol; Female; Fenofibrate; Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Probucol	1991
[Etofibrate in severe diet-refractory cases of hyperlipoproteinemia]. Fortschritte der Medizin, 1986, Apr-03, Volume: 104, Issue:13 Topics: Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Dietary Fats; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Triglycerides	1986